Stock listing

NASDAQ:OABI OmniAb, Inc. Stock

Home listing (NASDAQ) of OmniAb, Inc.

Follow OmniAb, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:OABI

$4.66 USD -0.42 (-8.3%)

Close on Nov 20, 2026

Past year +179.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.61 – $5.05 USDNov 20, 2026
Volume
1.90M sharesNov 20, 2026
Market cap
$679.7M USDAt the close on Nov 20, 2026 · price × 145.9M shares outstanding
52-week range
$1.35 – $5.45 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$6.99M USDMedian day 1.34M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
OmniAb, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:OABI · Home$4.66 USD-0.42 (-8.3%)1,898,284$4.90$5.05$4.61$5.08Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:OABI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.66-0.42-8.3%$4.90$5.05$4.611,898,284
$5.08+0.03+0.6%$5.05$5.174$5.001,215,073
$5.05+0.16+3.3%$4.89$5.07$4.801,263,886
$4.89-0.02-0.4%$4.85$4.935$4.731,234,643
$4.91-0.04-0.8%$4.95$4.97$4.85851,738
$4.95-0.15-2.9%$5.065$5.08$4.731,403,267
$5.100.000.0%$5.10$5.20$5.035789,290
$5.10-0.20-3.8%$5.25$5.35$4.8551,754,350
$5.30+0.27+5.4%$5.116$5.45$5.012,467,366
$5.03+0.20+4.1%$4.86$5.215$4.861,442,252
$4.83-0.35-6.8%$5.18$5.20$4.7951,246,045
$5.18+0.03+0.6%$5.285$5.36$5.001,142,445
$5.15+0.06+1.2%$5.12$5.37$5.0151,557,337
$5.09-0.02-0.4%$5.11$5.31$4.9352,148,641
$5.11-0.12-2.3%$4.40$5.11$4.392,110,453
$5.23-0.05-0.9%$5.37$5.405$5.141,677,670
$5.28+0.32+6.5%$4.92$5.29$4.9051,582,653
$4.96+0.35+7.6%$4.61$4.98$4.5491,113,208
$4.61-0.05-1.1%$4.66$4.72$4.53971,627
$4.66-0.12-2.5%$4.70$4.785$4.5151,283,200
$4.78-0.135-2.7%$4.91$5.055$4.711,336,600
$4.915-0.045-0.9%$4.96$5.132$4.803,176,500
$4.96+0.27+5.8%$4.74$5.105$4.741,930,800
$4.69+0.10+2.2%$4.53$4.755$4.52892,400
$4.59-0.14-3.0%$4.73$4.82$4.505969,400
$4.73+0.18+4.0%$4.60$4.755$4.531820,500
$4.55-0.15-3.2%$4.62$4.83$4.53737,800
$4.70-0.07-1.5%$4.76$4.815$4.62809,400
$4.77-0.02-0.4%$4.77$4.845$4.64988,600
$4.79+0.13+2.8%$4.66$4.915$4.591,038,100
$4.66+0.10+2.2%$4.41$4.66$4.2151,529,500
$4.56+0.21+4.8%$4.35$4.75$4.301,498,200
$4.35-0.57-11.6%$4.85$5.00$4.2152,002,200
$4.92+0.05+1.0%$4.83$5.02$4.641,215,100
$4.87-0.12-2.4%$5.04$5.09$4.811,623,600
$4.99+0.03+0.6%$4.94$5.055$4.8351,981,600
$4.96+0.22+4.6%$4.76$5.05$4.721,928,700
$4.740.000.0%$4.74$4.95$4.6151,391,900
$4.74+0.13+2.8%$4.61$4.81$4.55674,900
$4.61-0.18-3.8%$4.82$4.84$4.585783,600
$4.790.000.0%$4.75$4.865$4.631,044,800
$4.79-0.13-2.6%$4.90$4.995$4.6851,050,100
$4.92+0.34+7.4%$4.61$4.93$4.5451,375,000
$4.58+0.11+2.5%$4.50$4.64$4.451,363,900
$4.47+0.03+0.7%$4.43$4.50$4.301,862,000
$4.44+0.09+2.1%$4.44$4.455$4.25984,000
$4.350.000.0%$4.38$4.45$4.271,064,600
$4.35-0.13-2.9%$4.43$4.43$4.24788,700
$4.48+0.41+10.1%$4.13$4.535$4.121,599,200
$4.07+0.12+3.0%$3.97$4.11$3.891,315,800
$3.95-0.065-1.6%$3.922$4.075$3.911,393,700
$4.015-0.225-5.3%$4.21$4.27$3.971,203,300
$4.24-0.09-2.1%$4.30$4.33$4.1351,272,300
$4.33-0.42-8.8%$4.78$4.78$4.281,703,500
$4.75-0.29-5.8%$5.08$5.08$4.6252,004,600
$5.04+0.60+13.5%$4.47$5.43$4.475,082,600
$4.44+0.06+1.4%$4.35$4.45$4.321,155,200
$4.38-0.09-2.0%$4.44$4.46$4.331,179,200
$4.47-0.14-3.0%$4.54$4.58$4.4151,297,100
$4.61-0.20-4.2%$4.81$4.81$4.561,282,700
$4.81+0.15+3.2%$4.695$4.93$4.6351,442,200
$4.66-0.05-1.1%$4.68$4.78$4.581,467,054
$4.71+0.38+8.8%$4.40$4.71$4.201,941,317
$4.33+0.03+0.7%$4.31$4.535$4.141,851,700
$4.30+0.11+2.6%$4.188$4.59$4.162,253,100
Ticker
NASDAQ:OABI
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All OmniAb, Inc. news

OmniAb, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 53 in all · newest Oct 30, 2026 · oldest 2022
Calls
16 calls with a replay · 16 with a transcript · latest Oct 30, 2026
Decks
40 decks · latest Oct 30, 2026

Where OmniAb, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:OABI · Home listing · This pageNASDAQUnited StatesUSD
BOATS:OABIBOATSUnited StatesUSD

Valuation

EV/sales 15.3× against a median of 3.6×: the highest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$615.5M USD
P/E
Loss
EV/sales
15.3×
EV/EBITDA
Negative EBITDA
Price/book
2.7×
Gross margin
Not reported
Operating margin
−115.9%
Net margin
−108.1%
Debt to equity
0.0×
Beta vs S&P 500
1.29

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
OmniAb, Inc. · NASDAQ:OABIUS$679.7MUS$615.5Mn/a15.3×n/a2.7×−108.1%0.0×1.29
HOB Biotech Group Corp., Ltd. Class A · SSE:688656US$800.9MUS$789.4M204×12.8×n/a6.3×6.3%0.0×n/a
Cytek Biosciences, Inc. · NASDAQ:CTKBUS$800.4MUS$569.2Mn/a2.7×n/a2.5×−39.1%0.1×0.79
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. Class A · SSE:688621US$769.9MUS$694.3Mn/a4.6×n/a4.2×−0.2%0.0×n/a
Oxford BioMedica plc · LSE:OXBUS$767.3MUS$876.3Mn/a4.0×n/a10.1×−17.8%2.7×n/a
Beijing Hotgen Biotech Co. Ltd. Class A · SSE:688068US$758.2MUS$598.0Mn/a8.4×n/a2.1×−65.6%0.0×n/a
Maccura Biotechnology Co., Ltd. Class A · SZSE:300463US$722.4MUS$677.6Mn/a2.1×n/a0.8×−1.5%0.1×n/a
R&G PharmaStudies Co., Ltd. Class A · SZSE:301333US$706.0MUS$456.1M40.4×3.2×n/a2.4×12.2%0.0×n/a
SD Biosensor, Inc. · KRX:137310US$655.8MUS$520.0Mn/a0.9×11.5×0.4×−98.8%0.1×n/a
PharmaResources (Shanghai) Co., Ltd Class A · SZSE:301230US$641.2MUS$600.8M149×5.5×n/a4.2×4.0%0.0×n/a
Getein Biotech, Inc. Class A · SSE:603387US$608.2MUS$358.4M13.8×2.1×n/a1.4×26.3%0.0×n/a
Median of the othersUS$740.3MUS$599.4M94.9×3.6×11.5×2.4×−0.8%0.0×0.79

Forecasts

7 strong buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
8.33 USD · Analysts' mean
EPS, year to Dec 2026
-0.35 · 5 analysts
Revenue, year to Dec 2026
37.07M · 7 analysts

Team and board

Officers

OfficerRole
Matthew W. FoehrPresident and Chief Executive Officer
Kurt GustafsonChief Financial Officer
Amechi NwachukuChief Operating Officer
Charles BerkmanChief Legal Officer
Ellen SmithAssociate General Counsel, Intellectual Property and Licensing
Bill HarrimanSr. Vice President, Discovery Partnership Management, Technology Development and Operations
Bob ChenSr. Vice President, Discovery Systems
Chris SilviaVice President, Data Sciences and Corporate IT
Christel IfflandSr. Vice President, R&D Portfolio Management and Technology Operations
Cia McCaffreySr. Vice President, People and Talent
Neil CastleVice President, Biology
Todd PettingillVice President, Business Development and Strategy
Yasmina AbdicheSr. Vice President, Exploratory Research

Board

DirectorRole
John HigginsBoard Chair
Carolyn R. BertozziBoard Member
Jennifer CochranBoard Member
Matthew W. FoehrPresident and Chief Executive Officer
Philip J. GotwalsBoard Member

Events

Calls

CallWhenStatus
OmniAb (NASDAQ:OABI) Q3 2026 Earnings CallFri, Oct 30, 2026 · 8:00 AM ETReplay
OmniAb (NASDAQ:OABI) Q2 2026 Earnings CallThu, Aug 06, 2026 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q1 2026 Earnings CallThu, May 07, 2026 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q4 2025 Earnings CallWed, Mar 04, 2026 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q3 2025 Earnings CallTue, Nov 04, 2025 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q2 2025 Earnings CallWed, Aug 06, 2025 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q1 2025 Earnings CallThu, May 08, 2025 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q4 2024 Earnings CallTue, Mar 18, 2025 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q3 2024 Earnings CallTue, Nov 12, 2024 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q2 2024 Earnings CallThu, Aug 08, 2024 · 4:30 PM ETReplay
All 16 calls
CallWhenStatus
OmniAb (NASDAQ:OABI) Q1 2024 Earnings CallThu, May 09, 2024 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q4 2023 Earnings CallWed, Mar 20, 2024 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q3 2023 Earnings CallThu, Nov 09, 2023 · 11:00 AM ETReplay
OmniAb (NASDAQ:OABI) Q2 2023 Earnings CallThu, Aug 10, 2023 · 4:30 PM ETReplay
OmniAb (NASDAQ:OABI) Q1 2023 Earnings CallThu, May 11, 2023 · 8:30 AM ETReplay
OmniAb (NASDAQ:OABI) Q4 2022 Earnings CallThu, Mar 30, 2023 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 30, 2026 · Before open−2.3%
Q2 2026Aug 6, 2026 · After close+37.5%
Q1 2026May 7, 2026 · After close+12.9%
Q4 2025Mar 5, 2026+4.4%
Q3 2025Nov 4, 2025 · After close−3.7%
Q2 2025Aug 6, 2025 · After close−2.6%
Q1 2025May 8, 2025 · After close−8.3%
Q4 2024Mar 18, 2025 · After close−20.4%
Q3 2024Nov 12, 2024 · After close−9.3%
Q2 2024Aug 8, 2024 · After close−1.2%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close+2.4%
Q4 2023Mar 20, 2024 · After close−5.2%
Q3 2023Nov 9, 2023 · Before open−4.2%
Q2 2023Aug 10, 2023 · After close−5.5%
Q1 2023May 11, 2023 · After close+8.4%
Q4 2022Mar 30, 2023 · After close+4.8%
Q3 2022Nov 10, 2022 · After close−2.3%
Q2 2022Aug 12, 2022 · After close+0.2%
Q1 2022May 20, 2022 · After close−0.1%
Quarter to Dec 31, 2021Mar 28, 2022 · After close−0.0%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings27 slidesOct 30, 2026
Investor Day (October 2026)Investor day69 slidesOct 6, 2026
Q2 2026 Earnings PresentationEarnings24 slidesAug 6, 2026
Q1 2026 Earnings PresentationEarnings22 slidesMay 7, 2026
Q4 2025 Earnings PresentationEarnings26 slidesMar 4, 2026
AETC Scientific Briefing 2025Conference25 slidesDec 16, 2025
AETC 2025 Scientific Briefing #6Conference21 slidesDec 15, 2025
Jefferies Global Healthcare Conference London 2025Conference25 slidesNov 19, 2025
Q3 2025 Earnings PresentationEarnings24 slidesNov 4, 2025
Q2 2025 Earnings PresentationEarnings20 slidesAug 6, 2025
All 40 decks
DeckKindSlidesDate
Q2 2025 Earnings PresentationEarnings16 slidesAug 6, 2025
PEGS Boston 2025Conference32 slidesMay 13, 2025
Q1 2025 Earnings PresentationEarnings26 slidesMay 8, 2025
Q4 2024 Earnings PresentationEarnings28 slidesMar 18, 2025
Q3 2024 Earnings PresentationEarnings16 slidesNov 12, 2024
Q2 2024 Earnings PresentationEarnings20 slidesAug 8, 2024
Technical Presentation (May 2024)Technical37 slidesMay 15, 2024
Q1 2024 Earnings PresentationEarnings16 slidesMay 9, 2024
Q4 2023 Earnings PresentationEarnings24 slidesMar 20, 2024
Technical Presentation (December 2023)Technical31 slidesDec 15, 2023
Technical Presentation (December 2023)Technical26 slidesDec 14, 2023
PEGS Europe 2023Conference21 slidesNov 15, 2023
Q3 2023 Earnings PresentationEarnings68 slidesNov 9, 2023
Investor Presentation (August 2023)Investor deck35 slidesAug 10, 2023
Q2 2023 Earnings PresentationEarnings20 slidesAug 10, 2023
Investor Presentation (May 2023)Investor deck39 slidesMay 11, 2023
Q1 2023 Earnings PresentationEarnings17 slidesMay 11, 2023
PEGS 2023Conference37 slidesMay 2023
FY2022 Earnings PresentationEarnings22 slidesMar 30, 2023
Investor Presentation (January 2023)Investor deck38 slidesJanuary 2023
Technical Presentation (December 2022)Technical23 slidesDec 6, 2022
Stifel Healthcare Conference 2022Conference27 slidesNov 15, 2022
Credit Suisse 31st Annual Healthcare Conference 2022Conference43 slidesNov 9, 2022
Technical Presentation (October 2022)Technical21 slidesOct 18, 2022
13th World Bispecific Summit, Boston 2022Conference16 slidesSep 21, 2022
Avista Public Acquisition Corp. II — SPAC Merger (June 2022)SPAC merger80 slidesJun 21, 2022
SPAC Merger (March 2022)SPAC merger35 slidesMar 23, 2022
Technical Presentation (December 2021)Technical28 slidesDec 13, 2021
Technical Presentation (October 2020)Technical32 slidesOct 29, 2020
10th Annual World Bispecific Summit 2019Conference19 slidesSep 17, 2019

Open Decks

Financings

RaiseDate
Private placement of common stock
Announced: about US$30M · US$1.4 a share · Leerink Partners
Dealers: Leerink Partners (lead)
Insiders: Officers and directors participate at $1.85 per share
Use of proceeds: General corporate purposes
Aug 25, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as Avista Public Acquisition Corp. II, a blank check company (SPAC). Priced at US$10.00 a unit on Aug 9, 2021.

Price
US$10.00 a unit
Units offered
20,000,000 units
Offering size
US$200 million
Underwriters' option
Up to 3,000,000 more units
Listing
AHPAU on Nasdaq
Underwriter
Credit Suisse
Units delivered
On or about Aug 12, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceMar 19, 2021
Filed publiclyJun 17, 2021
Amended onceJul 28, 2021
Shares registered with an exchangeAug 9, 2021
Declared effective by the SECAug 9, 2021
Final prospectus, with the priceAug 11, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Aug 11, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue18.7M26.4M34.2M59.1M34.7M
Research and development47.8M55.1M56.5M48.4M39.2M
Operating income-69.0M-74.5M-69.4M-26.6M-35.6M
Depreciation and amortization21.8M23.6M19.5M18.2M16.3M
EBITDA-47.2M-50.9M-49.9M-8.40M-19.4M
Interest expense07.00K
Income before tax-66.3M-71.4M-64.4M-26.1M-34.4M
Income tax-1.51M-9.38M-13.7M-3.73M-7.31M
Net income-64.8M-62.0M-50.6M-22.3M-27.0M
Earnings per share, basic-0.57-0.61-0.51-0.26-0.33
Earnings per share, diluted-0.57-0.61-0.51-0.26-0.33

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents25.5M27.6M16.4M33.4M0
Short-term investments28.5M31.8M70.6M54.9M0
Receivables7.39M5.27M3.84M30.3M21.1M
Inventory823.0K48.0K
Current assets65.3M68.1M94.9M125.0M22.5M
Property, plant and equipment9.43M15.5M18.2M20.0M6.79M
Goodwill84.0M84.0M84.0M84.0M84.0M
Total assets300.9M325.6M375.2M421.2M304.5M
Accounts payable1.88M2.30M4.41M2.97M2.92M
Current liabilities16.3M15.1M23.1M26.0M20.6M
Total liabilities33.9M37.9M60.6M79.8M70.2M
Shareholders' equity267.0M287.6M314.6M341.4M234.3M
Shares outstanding144.3M121.6M116.9M115.2M0

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-36.5M-39.7M2.35M-3.59M-5.67M
Capital spending-565.0K-1.88M-1.64M-17.2M-4.07M
Free cash flow-37.0M-41.5M703.0K-20.8M-9.74M
Cash from investing6.47M37.9M-18.4M-73.3M-4.03M
Cash from financing27.9M13.0M-892.0K110.7M9.70M
Change in cash-2.07M11.2M-16.9M33.8M0

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 2, 2026Insider tradeSEC
10-Q · Quarterly reportOct 30, 2026Quarterly reportSEC
8-K · Current reportOct 30, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
4 · Change in ownershipAug 3, 2026Insider tradeSEC
3 · Initial statement of ownershipJul 13, 2026Insider tradeSEC
8-K · Current reportJul 13, 2026Management or board changeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
8-K · Current reportJun 18, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
4 · Change in ownershipApr 21, 2026Insider tradeSEC
4 · Change in ownershipApr 21, 2026Insider tradeSEC
144 · Notice of proposed saleApr 7, 2026Other filingsSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
144 · Notice of proposed saleApr 7, 2026Other filingsSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
144 · Notice of proposed saleApr 7, 2026Other filingsSEC
10-K · Annual reportMar 4, 2026Annual reportSEC
8-K · Current reportMar 4, 2026ResultsSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 17, 2026Insider tradeSEC
4 · Change in ownershipFeb 17, 2026Insider tradeSEC
4 · Change in ownershipFeb 17, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2026Big-stake noticeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
8-K · Current reportJan 30, 2026Current reportSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveSep 22, 2025Other filingsSEC
CORRESP · Letter to the SECSep 17, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 16, 2025Other filingsSEC
S-3 · Registration statementSep 12, 2025Offer documentSEC
DSep 10, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 27, 2025Big-stake noticeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
8-K · Current reportAug 25, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 6, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeJul 1, 2025Big-stake noticeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
8-K · Current reportJun 18, 2025Meeting outcomeSEC
SCHEDULE 13G · Big-stake noticeJun 6, 2025Big-stake noticeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
ARS · Annual report to shareholdersApr 29, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2025Meeting noticeSEC
4 · Change in ownershipApr 21, 2025Insider tradeSEC
3 · Initial statement of ownershipApr 21, 2025Insider tradeSEC
4 · Change in ownershipApr 21, 2025Insider tradeSEC
3 · Initial statement of ownershipApr 21, 2025Insider tradeSEC
8-K · Current reportApr 21, 2025Management or board changeSEC
4 · Change in ownershipApr 7, 2025Insider tradeSEC
4 · Change in ownershipApr 7, 2025Insider tradeSEC
4 · Change in ownershipApr 7, 2025Insider tradeSEC
144 · Notice of proposed saleApr 7, 2025Other filingsSEC
144 · Notice of proposed saleApr 7, 2025Other filingsSEC
144 · Notice of proposed saleApr 7, 2025Other filingsSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
144 · Notice of proposed saleApr 1, 2025Other filingsSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMar 18, 2025Offer documentSEC
10-K · Annual reportMar 18, 2025Annual reportSEC
8-K · Current reportMar 18, 2025ResultsSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 18, 2025Other filingsSEC
144 · Notice of proposed saleFeb 18, 2025Other filingsSEC
144 · Notice of proposed saleFeb 18, 2025Other filingsSEC
4 · Change in ownershipJan 30, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
144 · Notice of proposed saleJan 21, 2025Other filingsSEC
144 · Notice of proposed saleJan 21, 2025Other filingsSEC
144 · Notice of proposed saleJan 21, 2025Other filingsSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
144 · Notice of proposed saleDec 9, 2024Other filingsSEC
144 · Notice of proposed saleDec 9, 2024Other filingsSEC
144 · Notice of proposed saleDec 9, 2024Other filingsSEC
4 · Change in ownershipNov 26, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportNov 12, 2024ResultsSEC
4 · Change in ownershipNov 1, 2024Insider tradeSEC
4 · Change in ownershipNov 1, 2024Insider tradeSEC
UPLOAD · Letter from the SECSep 27, 2024Other filingsSEC
CORRESP · Letter to the SECSep 24, 2024Other filingsSEC
UPLOAD · Letter from the SECSep 11, 2024Other filingsSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 8, 2024ResultsSEC
4 · Change in ownershipJul 12, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJul 2, 2024Big-stake noticeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
8-K · Current reportJul 1, 2024Management or board changeSEC
4 · Change in ownershipJun 27, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
8-K · Current reportJun 20, 2024Meeting outcomeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
4/A · Change in ownership, amendedApr 23, 2024Insider tradeSEC
4/A · Change in ownership, amendedApr 23, 2024Insider tradeSEC
4/A · Change in ownership, amendedApr 23, 2024Insider tradeSEC
4/A · Change in ownership, amendedApr 23, 2024Insider tradeSEC
4/A · Change in ownership, amendedApr 23, 2024Insider tradeSEC
4 · Change in ownershipApr 9, 2024Insider tradeSEC
4 · Change in ownershipApr 9, 2024Insider tradeSEC
4 · Change in ownershipApr 9, 2024Insider tradeSEC
144 · Notice of proposed saleApr 8, 2024Other filingsSEC
144 · Notice of proposed saleApr 8, 2024Other filingsSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
144 · Notice of proposed saleApr 1, 2024Other filingsSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
10-K · Annual reportMar 25, 2024Annual reportSEC
4 · Change in ownershipMar 25, 2024Insider tradeSEC
8-K · Current reportMar 20, 2024ResultsSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
4 · Change in ownershipJan 31, 2024Insider tradeSEC
SC 13G · Big-stake noticeJan 29, 2024Big-stake noticeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveDec 19, 2023Other filingsSEC
EFFECT · Notice that a registration is effectiveDec 19, 2023Other filingsSEC
CORRESP · Letter to the SECDec 14, 2023Other filingsSEC
UPLOAD · Letter from the SECDec 13, 2023Other filingsSEC
4 · Change in ownershipDec 13, 2023Insider tradeSEC
4/A · Change in ownership, amendedDec 12, 2023Insider tradeSEC
4 · Change in ownershipDec 11, 2023Insider tradeSEC
4 · Change in ownershipDec 11, 2023Insider tradeSEC
4 · Change in ownershipDec 11, 2023Insider tradeSEC
POS AM · Amendment to an effective registrationDec 8, 2023Offer documentSEC
S-3 · Registration statementDec 8, 2023Offer documentSEC
4 · Change in ownershipNov 14, 2023Insider tradeSEC
4 · Change in ownershipNov 13, 2023Insider tradeSEC
424B3 · ProspectusNov 9, 2023Offer documentSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportNov 9, 2023ResultsSEC
4 · Change in ownershipNov 2, 2023Insider tradeSEC
424B3 · ProspectusNov 2, 2023Offer documentSEC
3 · Initial statement of ownershipNov 1, 2023Insider tradeSEC
4 · Change in ownershipNov 1, 2023Insider tradeSEC
8-K · Current reportNov 1, 2023Management or board changeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
424B3 · ProspectusAug 10, 2023Offer documentSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
8-K · Current reportAug 10, 2023ResultsSEC

This page holds 200 of 387 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from OmniAb, Inc.’s releases · as of Oct 23, 2026

Common shares
145,860,318
Fully diluted
145,860,318

Fully diluted

LineSharesAs of
Common shares145,860,318Oct 23, 2026

Share count over time

CountShares
Oct 23, 2026145,860,318

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Whitefort Capital Management, LP10.1M7.0%US$50.3MSep 30, 2026
BlackRock9.73M6.7%US$48.3MSep 30, 2026
Vanguard5.54M3.8%US$27.5MSep 30, 2026
Nomura5.03M3.4%US$24.9MSep 30, 2026
Cadian Capital Management, LP4.21M2.9%US$20.9MSep 30, 2026
Geode Capital2.81M1.9%US$14MSep 30, 2026
Rice Hall James & Associates, LLC2.54M1.7%US$12.6MSep 30, 2026
State Street2.28M1.6%US$11.3MSep 30, 2026
Private Management Group Inc2.01M1.4%US$9.99MSep 30, 2026
Arrowstreet Capital, Limited Partnership1.85M1.3%US$9.16MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Prudential Financial Inc1.41M0.97%US$7.02MSep 30, 2026
Two Sigma1.28M0.88%US$6.36MSep 30, 2026
D. E. Shaw & Co., Inc.1.28M0.88%US$6.34MSep 30, 2026
Dimensional1.24M0.85%US$6.15MSep 30, 2026
Stempoint Capital LP1.2M0.83%US$5.97MSep 30, 2026
Towerview LLC1.16M0.80%US$5.76MSep 30, 2026
Schwab1.01M0.69%US$5MSep 30, 2026
Northern Trust925K0.63%US$4.59MSep 30, 2026
Morgan Stanley920K0.63%US$4.56MSep 30, 2026
Millennium866K0.59%US$3.69MSep 30, 2026
Isthmus Partners, LLC802K0.55%US$3.98MSep 30, 2026
Renaissance Technologies752K0.52%US$3.73MSep 30, 2026
Parkman Healthcare Partners LLC726K0.50%US$3.6MSep 30, 2026
Goldman Sachs680K0.47%US$3.37MSep 30, 2026
Qube Research & Technologies Ltd603K0.41%US$2.99MSep 30, 2026
Nuveen580K0.40%US$2.88MSep 30, 2026
Connor, Clark & Lunn Investment Management Ltd.512K0.35%US$2.54MSep 30, 2026
Schonfeld Strategic Advisors LLC469K0.32%US$2.33MSep 30, 2026
UBS463K0.32%US$2.3MSep 30, 2026
Mackenzie439K0.30%US$2.18MSep 30, 2026
BNY320K0.22%US$1.59MSep 30, 2026
Integrated Quantitative Investments LLC249K0.17%US$1.24MSep 30, 2026
Balyasny Asset Management L.P.249K0.17%US$1.23MSep 30, 2026
Acadian Asset Management LLC239K0.16%US$1.18MSep 30, 2026
Fidelity235K0.16%US$1.16MSep 30, 2026
Algert Global LLC219K0.15%US$1.09MSep 30, 2026
Informed Momentum Co LLC209K0.14%US$1.04MSep 30, 2026
Bridgeway Capital Management, LLC196K0.13%US$971KSep 30, 2026
TLS Advisors LLC196K0.13%US$971KSep 30, 2026
XTX Topco Ltd193K0.13%US$957KSep 30, 2026
Arbiter Partners Capital Management LLC193K0.13%US$955KSep 30, 2026
Rhumbline Advisers191K0.13%US$946KSep 30, 2026
Legato Capital Management LLC188K0.13%US$932KSep 30, 2026
Bank of America185K0.13%US$917KSep 30, 2026
Empowered Funds, LLC182K0.12%US$902KSep 30, 2026
Sei Investments Co181K0.12%US$900KSep 30, 2026
AllianceBernstein156K0.11%US$774KSep 30, 2026
Invesco140K0.10%US$696KSep 30, 2026
Hrt Financial LP134K0.09%US$665KSep 30, 2026
AQR Capital Management LLC132K0.09%US$656KSep 30, 2026

This page holds 50 of 157 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
iShares Russell 2000 ETF2.8M1.9%US$6.88MJun 30, 2026
Vanguard Total Stock Market Index Fund2.38M1.6%US$5.85MJun 30, 2026
Vanguard Extended Market Index Fund1.39M0.95%US$3.42MJun 30, 2026
Fidelity Small Cap Index Fund1.2M0.82%US$2.37MJul 31, 2026
iShares Russell 2000 Value ETF1.02M0.70%US$2.51MJun 30, 2026
iShares Biotechnology ETF828K0.57%US$2.04MJun 30, 2026
Fidelity Extended Market Index Fund625K0.43%US$1.69MMay 31, 2026
Vanguard Russell 2000 Index Fund572K0.39%US$1.54MMay 31, 2026
Schwab U.S. Small-Cap ETF560K0.38%US$1.51MMay 31, 2026
College Retirement Equities Fund - Total Global Stock Account437K0.30%US$1.08MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
iShares Micro-Cap ETF369K0.25%US$908KJun 30, 2026
U.S. Small Cap Portfolio301K0.21%US$597KJul 31, 2026
Schwab Small-Cap Index Fund266K0.18%US$527KJul 31, 2026
Vanguard Health Care Index Fund257K0.18%US$695KMay 31, 2026
Clearwater Select Equity Fund236K0.16%US$582KJun 30, 2026
Master Small Cap Index Series212K0.15%US$520KJun 30, 2026
Fidelity Total Market Index Fund206K0.14%US$557KMay 31, 2026
Fidelity Enhanced Small Cap Core ETF187K0.13%US$461KJun 30, 2026
Ultra-Small Company Market Fund185K0.13%US$455KJun 30, 2026
Fidelity Series Total Market Index Fund177K0.12%US$478KMay 31, 2026
Fidelity Small Cap Value Index Fund153K0.11%US$377KJun 30, 2026
Nuveen Small Cap Blend Index Fund145K0.10%US$287KJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF130K0.09%US$320KJun 30, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF121K0.08%US$326KMay 31, 2026
EQ/2000 Managed Volatility Portfolio107K0.07%US$264KJun 30, 2026
Fidelity Nasdaq Composite Index Fund97,3590.07%US$263KMay 31, 2026
Schwab U.S. Broad Market ETF91,9080.06%US$248KMay 31, 2026
Invesco RAFI US 1500 Small-Mid ETF89,8460.06%US$178KJul 31, 2026
EQ/Small Company Index Portfolio79,3580.05%US$195KJun 30, 2026
U.S. Core Equity 2 Portfolio78,6060.05%US$156KJul 31, 2026
Vanguard Russell 2000 Value Index Fund75,6130.05%US$204KMay 31, 2026
U.S. Core Equity 1 Portfolio75,1150.05%US$149KJul 31, 2026
Dimensional U.S. Core Equity 2 ETF74,9740.05%US$148KJul 31, 2026
U.S. Micro Cap Portfolio70,6000.05%US$140KJul 31, 2026
LVIP State Street Small-Cap Index Fund68,4890.05%US$168KJun 30, 2026
EQ/AB Small Cap Growth Portfolio56,4840.04%US$139KJun 30, 2026
Nuveen Equity Index Fund54,7910.04%US$108KJul 31, 2026
Small Cap Index Fund54,7790.04%US$135KJun 30, 2026
Avantis U.S. Small Cap Equity ETF52,9630.04%US$143KMay 31, 2026
Global X Russell 2000 ETF52,5240.04%US$104KJul 31, 2026
Bridge Builder Small/Mid Cap Value Fund49,1850.03%US$121KJun 30, 2026
Schwab Total Stock Market Index Fund48,1330.03%US$95,303Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund44,6290.03%US$110KJun 30, 2026
Dimensional U.S. Small Cap ETF44,3030.03%US$87,720Jul 31, 2026
Goldman Sachs Absolute Return Tracker Fund40,7710.03%US$100KJun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio39,9560.03%US$98,292Jun 30, 2026
Small Cap Index Fund39,3770.03%US$106KMay 31, 2026
Vanguard Balanced Index Fund37,7960.03%US$92,978Jun 30, 2026
JPMorgan U.S. Small Company Fund37,2270.03%US$91,578Jun 30, 2026
MetLife Russell 2000 Index Portfolio36,3720.02%US$89,475Jun 30, 2026

This page holds 50 of 131 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Berkman Charles S
Officer: Chief Legal Officer
Sale7,157USD 1.49US$10,664Apr 7, 2026
Gustafson Kurt A
Officer: Executive VP, Finance and CFO
Sale6,913USD 1.49US$10,300Apr 7, 2026
Foehr Matthew W
Director, Officer: President and CEO
Sale19,244USD 1.49US$28,674Apr 7, 2026

Big stakes

StakeStakeSharesDateFiling
Robert Goldstein8.50%12.3MDec 31, 2025Schedule 13G
Whitefort Capital Management, LP7.10%10.2MJun 30, 2026Schedule 13G
Janus Henderson Group PLC0.80%948KJun 30, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sarah Boyce
Other companies: Atrium Therapeutics, Inc. (Chair · Since at least Feb 26, 2026); Contineum Therapeutics, Inc. (Director · Since at least Jun 24, 2024); Avidity Biosciences, Inc (President and CEO, Director · Since at least Jun 11, 2020); Berkeley Lights Inc (Director · Jul 16, 2020 – May 14, 2021 · Past); Ligand Pharmaceuticals Incorporated (Director · Oct 15, 2019 – Jun 10, 2022 · Past); Akcea Therapeutics Inc (President, Director · Apr 17, 2018 – Jul 15, 2019 · Past); Ionis Pharmaceuticals, Inc. (Chief Business Officer · Jan 1, 2015 – Jan 15, 2018 · Past)
Director · Nov 1, 2022 – Jun 18, 2024 · Past
David F Burgstahler
Other companies: Organogenesis Holdings Inc. (Director · Aug 17, 2018 – May 14, 2021 · Past); WideOpenWest Inc (Director · May 24, 2017 – Aug 6, 2019 · Past); Lantheus Holdings, Inc. (Director · Nov 21, 2016 – Sep 7, 2017 · Past); Syneos Health Inc (Director · Aug 24, 2016 – May 23, 2017 · Past); AngioDynamics, Inc. (Director · Jul 22, 2015 – Apr 12, 2017 · Past)
Director · Aug 9, 2021 – Jun 18, 2024 · Past
Kurt Gustafson
Other companies: Xencor, Inc. (Director · Since at least Jul 14, 2014); Niagen Bioscience, Inc. (Director · Oct 21, 2016 – Jun 17, 2021 · Past); Spectrum Pharmaceuticals Inc (EVP & Chief Financial Officer · Jun 3, 2013 – Mar 15, 2022 · Past); Halozyme Therapeutics, Inc. (Vice President and CFO · Apr 13, 2009 – Feb 4, 2013 · Past)
Chief Financial Officer · Since at least Nov 1, 2022
John Higgins
Other companies: Immunome, Inc. (Chief Scientific Officer · Since at least Oct 2, 2023); Bio-Techne Corp (Director · Since at least Jun 4, 2019); Ligand Pharmaceuticals Incorporated (Director · May 14, 2019 – Dec 28, 2022 · Past)
Board Chair · Since at least Nov 1, 2022
Matthew W. Foehr
Other companies: Viking Therapeutics, Inc. (Director · Since at least Apr 13, 2016); AIxCrypto Holdings, Inc. (Director · Nov 29, 2016 – Jan 21, 2020 · Past); Ligand Pharmaceuticals Incorporated (President and COO · Aug 5, 2016 – Jun 10, 2022 · Past)
President and Chief Executive Officer · Since at least Nov 1, 2022
Thompson Dean
Other companies: Hi-Crush Partners LP (Director · Aug 23, 2018 – Aug 23, 2018 · Past); Organogenesis Holdings Inc. (Director · Aug 17, 2018 – May 14, 2021 · Past); VWR Corp (Director · Oct 1, 2014 – Oct 7, 2014 · Past)
Director · Aug 9, 2021 – Jun 18, 2024 · Past
William E Klitgaard
Other companies: Zapata Quantum, Inc. (Director · Since at least Mar 28, 2024); Syneos Health Inc (Director · Mar 1, 2017 – Sep 28, 2023 · Past); Covance Inc (Corporate Sr. Vice President · Feb 23, 2006 – Feb 19, 2015 · Past)
Director · Aug 9, 2021 – Aug 9, 2021 · Past
Carolyn R. Bertozzi
Other companies: Eli Lilly and Company (Director · Since at least Nov 16, 2020); Alnylam Pharmaceuticals, Inc. (Director · Jan 5, 2023 – May 8, 2025 · Past)
Director · Since at least Nov 1, 2022
Charles C Harwood Jr
Other companies: Organogenesis Holdings Inc. (Director · Oct 7, 2016 – Dec 10, 2018 · Past); Syneos Health Inc (Director · Nov 6, 2014 – Aug 24, 2016 · Past)
Director · Aug 24, 2022 – Aug 24, 2022 · Past
Benjamin Silbert
Other companies: Organogenesis Holdings Inc. (General Counsel and Secretary · Oct 7, 2016 – Oct 7, 2016 · Past)
General Counsel · Aug 9, 2021 – Aug 9, 2021 · Past
All 30 people
PersonSeat
Jennifer Cochran
Other companies: Ligand Pharmaceuticals Incorporated (Director · Jul 12, 2021 – Jun 10, 2022 · Past)
Board Member · Since at least Nov 1, 2022
John Cafasso
Other companies: Organogenesis Holdings Inc. (Chief Financial Officer · Oct 7, 2016 – Oct 7, 2016 · Past)
Chief Financial Officer · Aug 9, 2021 – Aug 9, 2021 · Past
Philip J Gotwals
Other companies: Capricor Therapeutics, Inc. (Director · Since at least Jul 21, 2023)
Director · Since at least Apr 21, 2025
Philip J. Gotwals
Other companies: Capricor Therapeutics, Inc. (Director · Since at least Nov 4, 2026)
Board Member · Since at least May 8, 2025
Steven C Crouse
Other companies: Bio-Techne Corp (President - Diag & Spatial Bi · Since at least Mar 1, 2026)
Director · Since at least Apr 21, 2025
Steven Love
Other companies: Affymax Inc (Vice President, Finance · Aug 20, 2007 – May 4, 2010 · Past)
Director · Since at least Nov 1, 2023
Amanda N HeraviInvestor Relations Officer · Aug 9, 2021 – Aug 9, 2021 · Past
Amechi NwachukuChief Operating Officer · Since at least Jul 13, 2026
Bill HarrimanSr. Vice President, Discovery Partnership Management, Technology Development and Operations · Since at least Nov 4, 2026
Bob ChenSr. Vice President, Discovery Systems · Since at least May 13, 2025
Charles BerkmanChief Legal Officer · Since at least Apr 7, 2026
Chris SilviaVice President, Data Sciences and Corporate IT · Since at least Nov 4, 2026
Christel IfflandSr. Vice President, R&D Portfolio Management and Technology Operations · Since at least Nov 5, 2026
Cia McCaffreySr. Vice President, People and Talent · Since at least Nov 5, 2026
Ellen SmithAssociate General Counsel, Intellectual Property and Licensing · Since at least Nov 5, 2026
Joshua Alexander TamaroffDirector · Nov 1, 2022 – Jun 18, 2024 · Past
Neil CastleVice President, Biology · Since at least Nov 5, 2026
Robert GirardiExecutive Vice President · Aug 9, 2021 – Aug 9, 2021 · Past
Todd PettingillVice President, Business Development and Strategy · Since at least Aug 17, 2026
Yasmina AbdicheSr. Vice President, Exploratory Research · Since at least Dec 15, 2025

Open People

Log in to ask 6ix AI your own questions about OmniAb, Inc.